SUBSCRIBE
SUBSCRIBE

ARTBIO

IN THE PRESS
Press Releases
ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors
November 14, 2024
 · 
3 min read
Business
FogPharma and ARTBIO Announce Collaboration to Co-Develop Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies for the Treatment of Cancer
May 14, 2024
 · 
4 min read
BioMidwest
ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
May 7, 2024
 · 
3 min read
Business
ARTBIO and PharmaLogic Announce Supply Agreement for Lead-212 based Therapeutic Candidate AB001 for New York and Surrounding States
January 12, 2024
 · 
3 min read
SpectronRx and ARTBIO Join Forces to Develop and Manufacture Clinical Supply of Novel Alpha Radioligand Therapy AB001 for Indiana and Surrounding States
January 9, 2024
 · 
2 min read
Genetown
ARTBIO Raises Oversubscribed and Upsized $90 Million Series A Financing to Progress Pipeline and Isotope Technology Development for New Class of Alpha Radioligand Therapies
December 7, 2023
 · 
5 min read
Business
ARTBIO Announces Appointment of Nick Pullen, Ph.D., as Chief Scientific Officer
October 5, 2023
 · 
3 min read
Business
ARTBIO and SpectronRx Enter a Collaboration to Manufacture Key Components of ARTBIO’s AlphaDirect™ Technology
July 24, 2023
 · 
4 min read
Genetown
ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential
June 21, 2023
 · 
8 min read
JOBS